UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q/A
(Mark One)
|X| Quarterly Report Pursuant to Section 13 or 15(d)of the Securities
Exchange Act of 1934
For the period ended April 30, 1996
|_| Transition Report Pursuant to Section 13 or 15(d)of the Securities Exchange
Act of 1934.
For the transition period from __________________ to ___________________
Commission file number 1-10870
-------
BIOWHITTAKER, INC.
-----------------------------------------------------
(Exact name of Registrant as specified in its charter)
Delaware 95-3917176
------------------------------ -----------------
(State or other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
8830 Biggs Ford Road, Walkersville, Maryland 21793-0127
- -------------------------------------------- ------------------
(Address of Principal Executive Offices) (zip code)
(301) 898-7025
----------------------------------------------------
(Registrant's telephone number, including area code)
Indicate by check whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
|X| Yes |_| No
The number of shares outstanding of the Registrant's only class of
common stock as of April 30, 1996 was 10,759,199.
<PAGE>
BIOWHITTAKER, INC.
PART II. OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K.
(a) Exhibits
27. Financial Data Schedule.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.
BIOWHITTAKER, INC.
Date: July 18, 1996 By /S/PHILP L. ROHRER, JR.
---------------------- -------------------------------------
Philip L. Rohrer, Jr., Vice President
(Principal Financial Officer)
<PAGE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from
BioWhittaker's interim consolidated statement of income for the six months ended
April 30, 1996 and it's consoidated balance sheet as of April 30, 1996 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> OCT-31-1996
<PERIOD-END> APR-30-1996
<CASH> 1,470
<SECURITIES> 0
<RECEIVABLES> 9,144
<ALLOWANCES> 127
<INVENTORY> 20,082
<CURRENT-ASSETS> 34,372
<PP&E> 32,860
<DEPRECIATION> 16,145
<TOTAL-ASSETS> 64,091
<CURRENT-LIABILITIES> 14,072
<BONDS> 0
0
0
<COMMON> 108
<OTHER-SE> 45,254
<TOTAL-LIABILITY-AND-EQUITY> 64,091
<SALES> 25,471
<TOTAL-REVENUES> 25,471
<CGS> 13,665
<TOTAL-COSTS> 21,930
<OTHER-EXPENSES> 2,525
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 159
<INCOME-PRETAX> 857
<INCOME-TAX> 1,449
<INCOME-CONTINUING> (592)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (592)
<EPS-PRIMARY> (.05)
<EPS-DILUTED> (.05)
</TABLE>
